New Jersey’s once heavily restricted medical marijuana market continues to open up: MMJ businesses will now be able to sell vape cartridges filled with concentrates, a move that could boost dispensary sales and open new opportunities for makers of vaporizers and concentrates.

The move comes after the state Department of Health waived the previous ban, according to NJ.com.

Jeff Brown, assistant health commissioner, told NJ.com that relaxing MMJ product restrictions is a department priority.

But that’s just one business-friendly move that has occurred since Gov. Phil Murphy, a Democrat, assumed office in January. Here are other developments:

In March, the state added five qualifying medical conditions, including two kinds of chronic pain, anxiety, migraine and Tourette syndrome.

The state is doubling the number of medical marijuana licenses from six to 12. Earlier this month, New Jersey took in 146 applications for the new licenses and plans to award the dozen permits Nov. 1.

New Jersey could be poised to pass recreational marijuana legislation, perhaps as soon as this fall.

The liberalization already has had an effect: New Jersey’s MMJ program now serves 30,000 patients, nearly double from year-end 2017, according to the state Department of Health.

Marijuana Business Factbook 2018 projects New Jersey MMJ sales this year will reach $30 million-$35 million, up from $20 million-$25 million in 2017.